# US 2015/0104830 A1 · Avian cell line and its use in production of protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104830 A1
- Document ID: US20150104830A1
- Status: Published application
- Kind: A1
- Application number: 14/396,336
- Filed: 2013-05-02
- Published: 2015-04-16
- Earliest claimed: 2012-05-02
- Applicants: Friedrichloeffler- Institut; Institute of Process Engineering, Chinese Academy of Sciences
- Inventors: Manfred Wirth; Lijing Sun; Zhiguo Su; Roland Riebe; Jaeger Volker; Nadine Konisch
- Web page: https://patentgrep.com/patent/US20150104830A1

## CPC

- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 2510/02: Cells for production
- C12N 2760/16152: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention provides a process for generating an avian cell line of duck origin by a process comprising: —cultivating embryonic avian cells in cell culture medium, preferably comprising fetal calf serum (FBS) for more than 40 passages while reducing the concentration of FBS to 1-2% vol/vol FBS, —transferring passaged cells into cell culture medium having 0% FBS, —resulting in the generation of a non-embryonic avian cell line suitable for non-adherent growth, i.e. for growth in suspended culture.

## Claims

### Claim 1

Process for generating an avian cell line, comprising the steps of
cultivating these avian cells in cell culture medium in the absence of feeder cells, wherein the medium comprises fetal calf serum (FBS),
with passaging of cells while reducing the concentration of FBS gradually
for more than 40 passages, reducing the concentration of FBS to 1-2% vol/vol,
in static culture at 37° C. in a 5% CO2 atmosphere,
transferring of passaged cells into cell culture medium having 0% FBS,
resulting in the generation of a non-embryonic avian cell line suitable for non-adherent growth.

### Claim 2 (depends on 16)

Process according to claim 16, wherein the avian embryo is a duck embryo, aged 10-15 days.

### Claim 3 (depends on 1)

Process according to claim 1, wherein the cell line is non-embryonic due to absence of marker SSEA-1.

### Claim 4 (depends on 1)

Process according to claim 1, wherein the cell line is DSM ACC3149.

### Claim 5 (depends on 1)

Process according to claim 1, wherein the cell line is susceptible for infection by virus having specificity for mammals and upon transfection with a nucleic acid construct comprising an expression cassette encoding a protein is capable of expressing the encoded protein.

### Claim 6 (depends on 16)

Process according to claim 16, wherein the absence of a feeder cell is the absence of a cell of non-avian origin and the absence of a medium contacted by a cell of non-avian origin.

### Claim 7 (depends on 1)

Process according to claim 1, comprising selecting the resulting avian cell line for a cell line lacking expression of caveolin-1.

### Claim 8 (depends on 1)

Avian cell line for use in the production of protein, obtained by a process according to claim 1.

### Claim 9 (depends on 8)

Process for producing protein comprising the cultivation of an avian cell line, wherein the avian cell line is one according to claim 8.

### Claim 10 (depends on 9)

Process according to claim 9, wherein the cell line is transfected with a nucleic acid construct containing at least one expression cassette containing a nucleic acid sequence encoding the protein.

### Claim 11 (depends on 9)

Process according to claim 9, wherein the protein is a natural or a synthetic antibody having specificity for an antigen.

### Claim 12 (depends on 9)

Process according to claim 9, wherein the protein is a viral particle and the cell line is infected with an infectious viral particle.

### Claim 13 (depends on 12)

Process according to claim 12 wherein the viral particle is an attenuated virus and the process after cultivating the cell line in the presence of the viral particle comprising the step of separating the viral particles from the cell line.

### Claim 14 (depends on 12)

Process according to claim 12, wherein the viral particle is a wild-type virus which is infectious for human cells or for non-human animal cells, the process after cultivating the cell line in the presence of the viral particle comprising the step of separating the viral particles from the cell line and, previously or subsequently, inactivating the viral particles.

### Claim 15 (depends on 12)

Process according to claim 12, wherein the viral particle is a wild-type or attenuated Influenza A virus.

### Claim 16 (depends on 1)

Process According to claim 1, wherein the avian cells are derived from an avian embryo.
